Free Trial

Crest Nicholson (LON:CRST) Stock Rating Upgraded by JPMorgan Chase & Co.

Crest Nicholson logo with Consumer Cyclical background

Crest Nicholson (LON:CRST - Get Free Report) was upgraded by investment analysts at JPMorgan Chase & Co. to a "neutral" rating in a research report issued to clients and investors on Thursday, Marketbeat Ratings reports. The firm presently has a GBX 190 ($2.41) target price on the stock, up from their previous target price of GBX 180 ($2.29). JPMorgan Chase & Co.'s price objective points to a potential upside of 11.90% from the stock's current price.

Separately, Berenberg Bank cut their target price on shares of Crest Nicholson from GBX 280 ($3.56) to GBX 215 ($2.73) and set a "hold" rating for the company in a research report on Tuesday, October 22nd.

Read Our Latest Stock Report on CRST

Crest Nicholson Price Performance

Shares of Crest Nicholson stock traded down GBX 2.60 ($0.03) during trading on Thursday, hitting GBX 169.80 ($2.16). The stock had a trading volume of 703,042 shares, compared to its average volume of 1,455,906. The company has a current ratio of 3.13, a quick ratio of 0.72 and a debt-to-equity ratio of 13.12. Crest Nicholson has a 12 month low of GBX 145.20 ($1.84) and a 12 month high of GBX 272.40 ($3.46). The firm has a market cap of £435.23 million, a price-to-earnings ratio of -1,721.00, a P/E/G ratio of 0.51 and a beta of 2.00. The business's 50-day moving average is GBX 172.91 and its 200 day moving average is GBX 211.03.

Crest Nicholson Company Profile

(Get Free Report)

Crest Nicholson Holdings plc engages in building residential homes in the United Kingdom. It develops and sells apartments, houses, and commercial properties. The company was founded in 1963 and is headquartered in Addlestone, the United Kingdom.

Further Reading

Should you invest $1,000 in Crest Nicholson right now?

Before you consider Crest Nicholson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crest Nicholson wasn't on the list.

While Crest Nicholson currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group (UNH) is a powerhouse in healthcare, offering an impressive 14.7% average annual dividend increase over the last three years.

Related Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines